Alaffia Health Announces $55 Million Series B

Gunderson Dettmer represented Alaffia Health, the leader in agentic AI for health plan claims operations, in its $55 million Series B financing. The round was led by Transformation Capital with participation from FirstMark Capital, Tau Ventures, and Twine Ventures.

Alaffia partners with leading regional and national health plans to help them scale clinical review capacity and unlock significant savings. The company will use the new capital to accelerate growth across three core areas: research and development, innovation, and market expansion. It plans to advance best-in-class AI, engineering, and product development, launch new AI agents across additional modalities to expand platform capabilities, and scale AI adoption to meet rising demand across the healthcare ecosystem.

“Health plans are under immense pressure to reduce administrative costs and drive affordability for their members, and like many industries, they’re starting to see the value of emerging AI solutions,” said TJ Ademiluyi, co-founder and CEO of Alaffia, in the announcement of the transaction. “With this funding, we’re expanding our team and platform so we can continue solving some of the most expensive operational challenges in healthcare and ultimately reduce the burden on the system as a whole.”

The Gunderson deal team was led by Randall Clark and included Katie Gardner, Darryl Long, Erica Davis, Lawrence Ho, and Christina Somaraju.

Companies
Alaffia Health
Transformation Capital
FirstMark Capital
Tau Ventures
Twine Ventures